Literature DB >> 21887902

Insulin resistance is associated with increased cardiovascular risk in Asian Indians with normal glucose tolerance--the Chennai Urban Rural Epidemiology Study (CURES-66).

S Sandeep1, K Gokulakrishnan, M Deepa, V Mohan.   

Abstract

OBJECTIVE: The aim of the study was to assess the association of Insulin Resistance [IR] assessed by Homeostasis Assessment model (HOMA-IR) with cardiovascular risk factors in subjects with Normal Glucose Tolerance [NGT] in Asian Indians.
METHODS: This cross-sectional study recruited subjects from the Chennai Urban Rural Epidemiology Study [CURES] an epidemiological study in a representative population of Chennai [formerly Madras], in South India. We included 1550 subjects with normal glucose tolerance, ie, fasting plasma glucose < 100 mg/dl [5.6 mmol/L] and 2 hour post load plasma glucose < 140 mg/dl [7.8 mmol/L]. IR was calculated using the homeostasis assessment model (HOMA-IR) using the formula: fasting insulin (1IU/mL) fasting glucose (mmol/L)/22.5. Metabolic syndrome [MS] was defined based on modified Adult Treatment Panel III (ATP III) guidelines.
RESULTS: HOMA-IR was found to be significantly associated with systolic blood pressure (beta = 0.100, p < 0.001), diastolic pressure (beta = 0.094, p < 0.001), total cholesterol (beta = 0.068, p = 0.005), serum triglycerides (beta = 0.105, p < 0.001), LDL cholesterol (beta = 0.118, p < 0.005), and HDL cholesterol (beta = -0.060, p < 0.001) even after adjusting age, gender and BMI. Subjects with family history of type 2 diabetes had significantly higher HOMA-IR [p = 0.011] compared to those without family history. In relation to physical activity, subjects with heavy grade activity had significantly lower HOMA-IR values compared to the light grade activity [p < 0.001] Subjects with generalized obesity [p < 0.001] and abdominal obesity [p < 0.001] had significantly higher HOMA-IR which remained statistically significant even after adjusting for age and gender. There was a linear increase in the mean values of HOMA IR with increase in number of components of MS [p for trend < 0.001]
CONCLUSION: Among Asian Indians who are known to have high risk of premature coronary artery disease and diabetes, a significant association exists between insulin resistance with cardiovascular risk factors even among NGT subjects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887902

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

1.  Genome-wide association study identifies novel recessive genetic variants for high TGs in an Arab population.

Authors:  Prashantha Hebbar; Rasheeba Nizam; Motasem Melhem; Fadi Alkayal; Naser Elkum; Sumi Elsa John; Jaakko Tuomilehto; Osama Alsmadi; Thangavel Alphonse Thanaraj
Journal:  J Lipid Res       Date:  2018-08-14       Impact factor: 5.922

2.  The effect of prior walking on coronary heart disease risk markers in South Asian and European men.

Authors:  Saravana Pillai Arjunan; Kevin Deighton; Nicolette C Bishop; James King; Alvaro Reischak-Oliveira; Alice Rogan; Matthew Sedgwick; Alice E Thackray; David Webb; David J Stensel
Journal:  Eur J Appl Physiol       Date:  2015-10-05       Impact factor: 3.078

Review 3.  N6-Adenosine Methylation (m6A) RNA Modification: an Emerging Role in Cardiovascular Diseases.

Authors:  Ye-Shi Chen; Xin-Ping Ouyang; Xiao-Hua Yu; Petr Novák; Le Zhou; Ping-Ping He; Kai Yin
Journal:  J Cardiovasc Transl Res       Date:  2021-02-25       Impact factor: 4.132

4.  Associations of insulin resistance with cardiovascular risk factors and inflammatory cytokines in normal-weight Hispanic women.

Authors:  Chantal A Vella; Ximena Burgos; Carla J Ellis; Raul Y Zubia; Diana Ontiveros; Hector Reyes; Claudia Lozano
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

5.  Relation of insulin resistance with social-demographics, adiposity and behavioral factors in non-diabetic adult Canadians.

Authors:  Sai Yi Pan; Margaret de Groh; Alfred Aziz; Howard Morrison
Journal:  J Diabetes Metab Disord       Date:  2016-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.